AI Finds 23 Antiviral Leads for Deadly Ebola Strain

Scientists at the Southwest Research Institute (SwRI) and Texas Biomedical Research Institute have identified 23 antiviral candidates to fight the Bundibugyo Ebola strain ^[1][2]. Using AI-driven drug discovery platforms, the research teams screened and synthesized these compounds for further testing ^[1]. This collaborative effort focuses on finding effective treatments for this specific and deadly version of the virus ^[2][3].

The AI tools allowed researchers to quickly screen compounds that are most likely to be effective in the human body ^[1]. Traditionally, finding such leads takes years, but these digital platforms shortened the timeline significantly ^[1][3]. The identified candidates will now undergo testing to determine their safety and success against the virus ^[2].